COVID ENTRY BY CELL RECEPTORS

1. SARS-COV-2 cell entry depends on ACE2 and TMPRSS2
receptor and is blocked by clinically proven protease
inhibitor
Submitted To :-
Dr. Monika Asthana
Dr. Avnish Kumar
Dr. Bhavyata Dua
Department of Biotechnology
School of Life Sciences
Khandari Campus
DBRAU AGRA
Submitted by :-
HRIDYESH RIYAR
M.sc Biotechnology
4th Semester

2. SARS-COV-2
SARS-COV-2 is the virus strain that causes
corona virus disease 2019 (COVID-19).
Corona virus belongs to the family
coronaviridae.
Corona virus originated from WUHAN china.
WHO called this disease is corona virus disease
or simply called COVID-19.
Other name is SARS-COV-2 [severe acute
respiratory syndrome corona virus-2]

3. HISTORY

4. Biological structure of SARS-COV-2

5. HOW DOES IT INFECT THE CELL?

6. CLINICALLY APPROVED
MEDICATION

7. DIFFERENCE BETWEEN NORMAL LIFE CYCLE AND CLINICALLY
APPROVED MEDICATION

8. Goal
• The goal of the study was to obtain insights
into how SARS-COV-2 facilitates viral entry
into target cells and how this process can be
blocked.

10. RESULTS

11. DISCUSSION

12. SUMMARY

13. RESPOND SUGGESTION

14. CURRENT TREATMENTS